Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06821945
PHASE2

A Clinical Trial to Evaluate the Safety and Efficacy of Olanzapine Titration Schedule in Patients With Schizophrenia

Sponsor: Boryung Pharmaceutical Co., Ltd

View on ClinicalTrials.gov

Summary

The objective of this clinical trial is to evaluate the safety and efficacy of olanzapine titration schedule in patients with schizophrenia

Official title: A Multi-Center, Randomized, Double-Blind, Parallel-Design, Exploratory Clinical Trial to Evaluate the Safety and Efficacy of Olanzapine Titration Schedule in Patients With Schizophrenia

Key Details

Gender

All

Age Range

19 Years - Any

Study Type

INTERVENTIONAL

Enrollment

120

Start Date

2025-05-30

Completion Date

2027-05

Last Updated

2025-09-15

Healthy Volunteers

No

Conditions

Interventions

DRUG

BR5402A

Subjects take the investigational products once a day

DRUG

BR5402A-1

Subjects take the investigational products once a day

DRUG

BR5402B

Subjects take the investigational products once a day

DRUG

BR5402B-1

Subjects take the investigational products once a day

DRUG

BR5402C

Subjects take the investigational products once a day

DRUG

BR5402C-1

Subjects take the investigational products once a day

DRUG

BR5402D

Subjects take the investigational products once a day

DRUG

BR5402D-1

Subjects take the investigational products once a day

Locations (2)

Kyungbook National university hospital

Daegu, South Korea

Hanyang University Guri Hospital

Guri-si, South Korea